drug

r-gemox

1 story · latest Nov 3, 2026

Follow r-gemox. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Hutchmed

Timeline

Genmab's EPCORE DLBCL-1 Phase 3 trial posts results after primary completion in October 2026

Nov 3Trial updateAbbVie epcoritamab-bysp

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.